Nucleotide sequences for gene regulation and methods of use thereof
AssigneeThe Regents of the University of Michigan
InventorsKotoku Kurachi, Sumiko Kurachi
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of Michigan
InventorsKotoku Kurachi, Sumiko Kurachi
Estimating the term…
The invention provides nucleic acid sequences which regulate expression of a nucleotide sequence of interest. In particular, the invention provides nucleic acid sequences which regulate expression of a nucleotide sequence of interest in an age-related manner and/or in a liver-specific manner. The invention further provides methods of using the regulatory nucleic acid sequences provided herein for age-related and/or liver-specific expression of nucleotides sequences of interest. The invention also provides host cells and transgenic non-human animals which harbor the regulatory nucleic acid sequences of the invention. The compositions and methods of the invention are useful in regulating expression of a nucleotide sequence of interest in an age-related and/or liver-specific manner.
A recombinant expression vector comprising in operable combination i) a nucleic acid sequence of interest, ii) a promoter sequence, and iii) one or more age regulatory sequences selected from the group consisting of SEQ ID NO:1 and a functional portion of SEQ ID NO:1, wherein said age regulatory sequence is located at a position selected from the group consisting of the 3′ end of said promoter sequence, the 3′ end of said nucleic acid sequence of interest, and the 3′ end and 5′ end of said promoter sequence.
A recombinant expression vector comprising in operable combination i) a nucleic acid sequence encoding a factor IX protein, ii) a human factor IX promoter sequence, and iii) one or more age regulatory sequences selected from the group consisting of SEQ ID NO:2, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37, and SEQ ID NO:38, wherein said age regulatory sequence is located at a position selected from the 3′ end of said human factor IX promoter sequence and the 3′ end of said nucleic acid sequence.
A method of expressing Factor IX in a mouse, comprising:
A recombinant expression vector, comprising in operable combination i) a nucleic acid sequence of interest, ii) a promoter sequence, and iii) an age regulatory sequences selected from the group consisting of SEQ ID NO:2, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37, and SEQ ID NO:38, wherein said age regulatory sequence is located at the 3′ end of said promoter sequence.
A method of expressing Factor IX in a mouse, comprising:
A recombinant expression vector comprising in the 5′ to the 3′ order:
A recombinant expression vector comprising in the 5′ to 3′ order:
A transgenic mouse comprising a transgene, said transgene comprising:
A transgenic mouse comprising a transgene, said transgene comprising:
Dependencies are inferred from the claim text.